Delivery Order SPE2DB22D3501-SPE2DB24FUZ98
Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $7.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $11,167.10 and a period of performance through March 21, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET with a ceiling value of $20,961.86 and a period of performance through April 2025. The award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $18,086.54 and a period of performance through June 16, 2025. The contract is not set aside and was awarded on June 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $12,153.60, and a period of performance through June 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $3,007.71, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,456.13 delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $21,163.23 and an ultimate completion date of March 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a ceiling value of $6,242.82 and a period of performance through March 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,566,093,132 units of the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $23,977.29 and a period of performance through October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
- This is a $49,941.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has an ultimate completion date of August 6, 2024 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...